Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
E For L Aim PCLBKK:EFORL-R 40 EV-to-Revenue is 0.63 as of Sep. 03, 2026, which is 46% below its 10-year median of 1.16. GuruFocus rates BKK:EFORL-R with a GF Score™ of 40/100 and a GF Value™ of ฿0.14 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 120 Medical Distribution companies, E For L Aim PCL ranks better than 50% on this metric.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, E For L Aim PCL's enterprise value is ฿733 Mil.
E For L Aim PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ฿1,168 Mil. Therefore, E For L Aim PCL's EV-to-Revenue for today is 0.63.
The historical rank and industry rank for E For L Aim PCL's EV-to-Revenue or its related term are showing as below:
BKK:EFORL-R'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.18 Med: 1.16 Max: 4.92
Current: 0.63
During the past 13 years, the highest EV-to-Revenue of E For L Aim PCL was 4.92. The lowest was 0.18. And the median was 1.16.
BKK:EFORL-R's EV-to-Revenue is ranked better than 50% of 120
companies
in the Medical Distribution industry
Industry Median: 0.61
vs BKK:EFORL-R: 0.63
As of today (2026-09-03), E For L Aim PCL's stock price is ฿0.12.
E For L Aim PCL's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ฿0.29. Therefore, E For L Aim PCL's PS Ratio for today is 0.41.
E For L Aim PCL's share price for today is ฿0.12.
E For L Aim PCL's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
E For L Aim PCL EV-to-Revenue Related Terms
E For L Aim PCL EV-to-Revenue Historical Data
* Premium members only.
The historical data trend for E For L Aim PCL's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:EFORL-R vs MCK, COR, CAH: EV-to-Revenue Comparison
For the Medical Distribution subindustry, E For L Aim PCL's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
E For L Aim PCL EV-to-Revenue vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, E For L Aim PCL's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where E For L Aim PCL's EV-to-Revenue falls into.
E For L Aim PCL's current Enterprise Value is ฿733 Mil.
E For L Aim PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿1,168 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
E For L Aim PCL (BKK:EFORL-R) has a EV-to-Revenue of 0.63 as of Sep. 03, 2026. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on E For L Aim PCL and its competitors. This is 46% below median its historical median of 1.16. Over the past decade, E For L Aim PCL's EV-to-Revenue has ranged from 0.18 to 4.92. According to the industry distribution chart, E For L Aim PCL ranks #60 out of 120 companies in the Medical Distribution industry, placing it in the top 50%.
Is E For L Aim PCL's EV-to-Revenue too high?
E For L Aim PCL's current EV-to-Revenue of 0.63 is 46% below median its 10-year median of 1.16. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 4.92. The Medical Distribution industry median EV-to-Revenue is 0.61. E For L Aim PCL's value of 0.63 is 3.3% above this industry median. Based on the distribution chart, E For L Aim PCL ranks #60 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, E For L Aim PCL has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does E For L Aim PCL's EV-to-Revenue compare to MCK and COR?
According to the Medical Distribution industry distribution chart, E For L Aim PCL ranks #60 out of 120 companies for EV-to-Revenue. This puts E For L Aim PCL in the upper half of its industry. The industry median EV-to-Revenue is 0.61. E For L Aim PCL's value of 0.63 is 3.3% above this benchmark. Historically, E For L Aim PCL's own EV-to-Revenue has ranged from 0.18 to 4.92 over the past decade. While the company's 10-year median is 1.16 vs. the industry median of 0.61, E For L Aim PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-Revenue for a Medical Distribution company?
The median EV-to-Revenue among Medical Distribution companies is 0.61, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-Revenue significantly above this median, while those in the bottom quartile fall well below. However, EV-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. E For L Aim PCL's current EV-to-Revenue of 0.63 is 3.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-Revenue mean?
A high EV-to-Revenue can signal that a stock is expensive relative to its fundamentals. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on E For L Aim PCL and its competitors. For the Medical Distribution industry, the median EV-to-Revenue is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. E For L Aim PCL's current EV-to-Revenue is 0.63, which is 46% below median its own 10-year median of 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is E For L Aim PCL stock overvalued right now?
Based on GuruFocus' analysis, E For L Aim PCL (BKK:EFORL-R) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿0.14, compared to a current price of ฿0.12 — trading 14.3% below its estimated fair value. The current EV-to-Revenue is 0.63, which is 46% below median its 10-year median of 1.16 and 3.3% above the Medical Distribution industry median of 0.61. E For L Aim PCL's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-Revenue calculated?
EV-to-Revenue is calculated from a company's financial statements. For E For L Aim PCL (BKK:EFORL-R), the current EV-to-Revenue is 0.63 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is E For L Aim PCL (BKK:EFORL-R) Overvalued in 2026?
Based on GuruFocus' analysis, E For L Aim PCL stock appears to be undervalued.
The current stock price of ฿0.12 is trading 14.3% below its estimated GF Value™ of ฿0.14.
GuruFocus considers E For L Aim PCL to be Modestly Undervalued.
Key valuation signals for BKK:EFORL-R:
EV-to-Revenue: 0.63 (46% below median its 10-year median of 1.16)
GF Value™: ฿0.14 vs. price of ฿0.12 (14.3% below fair value)
Industry Position: 3.3% above the Medical Distribution median (#60 of 120)
No single metric tells the full story. See the BKK:EFORL-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
E For L Aim PCL is engaged in the distribution of medical devices and equipment. The company and subsidiary have distributor agreements for medical devices and equipment with foreign companies. Its products include Patient Monitor System, Central Monitors System, Defibrillator, Automated External Defibrillator (AED), Electrocardiographs, Electroencephalogram (EEG), PSG System (Sleep Labs), and Accessories and Consumables. The group is principally engaged in one operating segment which is the distribution of medical device and equipment and providing service of medical equipment. Their operations are carried out in Thailand.
40GF Score
Get the complete analysis for BKK:EFORL-R
EV-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:EFORL-R has been successfully added to your 
